Alembic Pharma's JV Aleor Dermaceuticals gets tentative nod from USFDA for testosterone gel

Aleor Dermaceuticals has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Testosterone Gel, 1.62 per cent (20.25 mg/1.25 gm actuation), Alembic Pharmaceuticals said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3m5A5WB
via IFTTT